Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > Let's call this a "not Red" perspective
View:
Post by donkeyfeathers on May 04, 2021 10:33am

Let's call this a "not Red" perspective

Hey Red, here is another way of looking at today's announcement...

It appears that all is not tickity-boo when it comes to “closing a collaboration deal” near term.  Why do I come to this conclusion?  The recent nominee’s background is in pharmaceuticals, not RM devices.  Some snarky comment like “could it be that islets can now be packaged in pill form, prior to being placed in a pouch?” is not the (sarcastic) point here.  Apologies to Dr. A for letting the frustration surface.

The point is, there is an AGM approaching and there has been nothing other than value destruction since January.  Nowhere in the PR does it say that Dr. Azab’s background is in the disciplines of “turn-around” agent or “CEO whisperer” or “IR leach remover”.  If he’d been quoted as possessing those qualities as part of his “additional perspectives” that he plans to bring, I think the value of a share of SVA would be up today.  

Detached (chilled?) me realizes NONE of those qualities are announced in a news release.  Detached (chilled?? really?) me also realizes that there has been plenty of chatter here and on other boards about the LJ/Can-o-worms participation that has paralleled the value destruction from the $2.80’s.  If Phillip and Frank see this nomination as an inflection point (and not a pacifying pill), they’d better do a better job than simply announcing the nomination.  There is way too much investor distrust from some of us at this point, to not wonder if this isn’t anything more than a “stacking exercise”.  You can’t hide behind a BOD nomination gents.  Either get this company to a place of value realization, quickly, or there will be more than a few pills popped in June.

DF

Comment by steadfast on May 04, 2021 1:25pm
Another Excellent Post, Donkeyfeathers: Your sentence "there has been nothing othan than value destruction since January" is 100% true.  January 2021 SVA starts to participate in TheMarket Melt Up and is rewarded by Dr Witkowski on Fri Jan 15th with World Class Data, the excitement continues at open Mon morning reaching a high of $2.87.  SVA has been given a golden opportunity ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities